Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine: Preclinical Studies

Since the emergence of SARS-CoV-2 at the end of 2019, 64 candidate vaccines are in clinical development and 173 are in the pre-clinical phase. Five types of vaccines are currently approved for emergency use in many countries (Inactivated, Sinopharm; Viral-vector, Astrazeneca, and Gamaleya Research I...

Descripción completa

Detalles Bibliográficos
Autores principales: Kandeil, Ahmed, Mostafa, Ahmed, Hegazy, Rehab R., El-Shesheny, Rabeh, El Taweel, Ahmed, Gomaa, Mokhtar R., Shehata, Mahmoud, Elbaset, Marawan A., Kayed, Ahmed E., Mahmoud, Sara H., Moatasim, Yassmin, Kutkat, Omnia, Yassen, Noha N., Shabana, Marwa E., GabAllah, Mohamed, Kamel, Mina Nabil, Abo Shama, Noura M., El Sayes, Mohamed, Ahmed, Amira N., Elalfy, Zahraa S., Mohamed, Bassim MSA, Abd El-Fattah, Safa N., El Hariri, Hazem Mohamed, Abdel Kader, Mona, Azmy, Osama, Kayali, Ghazi, Ali, Mohamed A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999656/
https://www.ncbi.nlm.nih.gov/pubmed/33802467
http://dx.doi.org/10.3390/vaccines9030214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999656/
https://www.ncbi.nlm.nih.gov/pubmed/33802467
http://dx.doi.org/10.3390/vaccines9030214

Ejemplares similares